Reuters -- U.S. regulators said on Wednesday they have found no link between oral bisphosphonate osteoporosis medications such as Merck & Co Inc’s (MRK.N) Fosamax and certain thigh bone fractures.
Reuters -- U.S. regulators said on Wednesday they have found no link between oral bisphosphonate osteoporosis medications such as Merck & Co Inc’s (MRK.N) Fosamax and certain thigh bone fractures.